Ditchcarbon
  • Customers
  1. Organizations
  2. Camurus
Public Profile
Pharmaceutical Preparation Manufacturing
SE
updated 5 days ago

Camurus

Company website

Camurus AB, a pioneering biopharmaceutical company headquartered in Sweden, focuses on developing innovative medicines for patients with severe and chronic conditions. Founded in 2016, Camurus has rapidly established itself in the pharmaceutical industry, particularly in the fields of pain management and addiction treatment. The company is renowned for its proprietary FluidCrystal® technology, which enables the formulation of long-acting injectable therapies. This unique approach enhances patient compliance and treatment outcomes. Camurus has achieved significant milestones, including the successful launch of its lead product, Buvidal®, for opioid dependence, positioning itself as a leader in the market. With a strong presence in Europe and expanding operations globally, Camurus continues to make strides in improving patient care through its advanced therapeutic solutions.

DitchCarbon Score

How does Camurus's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

38

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Camurus's score of 38 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.

63%

Let us know if this data was useful to you

Camurus's reported carbon emissions

In 2023, Camurus reported total carbon emissions of approximately 5,618,000 kg CO2e. This figure includes Scope 1 emissions of about 1,589,000 kg CO2e, primarily from mobile combustion, and Scope 2 emissions of approximately 1,748,000 kg CO2e, with a market-based total of about 17,480 kg CO2e. Additionally, Scope 3 emissions were significant, totalling around 3,856,000 kg CO2e, with notable contributions from purchased goods and services and downstream transportation and distribution. In comparison, the previous year, 2022, Camurus's total emissions were about 231,600 kg CO2e, with Scope 1 emissions at approximately 162,400 kg CO2e and Scope 2 emissions at about 8,990 kg CO2e. Scope 3 emissions for 2022 were around 60,300 kg CO2e, primarily from fuel and energy-related activities. Camurus has set a long-term commitment to achieve carbon neutrality by 2040, specifically targeting Scope 1 emissions. This ambitious goal reflects the company's dedication to reducing its carbon footprint and contributing to global climate efforts. The emissions data is sourced directly from Camurus AB (publ) and is not cascaded from any parent organization.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20222023
Scope 1
162,400
0,000,000
Scope 2
8,990
00,000
Scope 3
60,300
0,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Camurus's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Camurus is in SE, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Camurus is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Td Medtekhnologii, Ooo

RU
•
Food products nec
Updated 2 days ago

Fortovia Therapeutics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Jazz Pharmaceuticals (EUSA Pharma USA) Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Astra Tech GesmbH (Austria)

AT
Updated about 1 month ago

Abeona Therapeutics Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

Rocca & Partners Stichting Administratiekantoor Aandelen San Faustin

NL
Updated 8 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
dev
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy